Costa Rica vs Kazakhstan: Treatment for hypertension, female
Costa Rica
76.1%
in 2019
Kazakhstan
74.3%
in 2019
Costa Rica rank
2nd
Kazakhstan rank
3rd
Treatment for hypertension, female over time
- Costa Rica
- Kazakhstan
How they compare
Costa Rica currently reports 76.1% against 74.3% in Kazakhstan, a difference of 1.8%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Kazakhstan ahead.
Costa Rica ranks 2nd and Kazakhstan ranks 3rd of 192 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 45.0% | 51.7% | 6.6% | Kazakhstan |
| 2000s | 58.3% | 64.6% | 6.4% | Kazakhstan |
| 2010s | 72.4% | 72.5% | 0.1% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment for hypertension, female, Costa Rica or Kazakhstan?
- Costa Rica, at 76.1% against 74.3% in Kazakhstan as of 2019.
- What is the difference in treatment for hypertension, female between Costa Rica and Kazakhstan?
- 1.8%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Kazakhstan?
- 30 years are reported by both, from 1990 to 2019.
- How do Costa Rica and Kazakhstan rank globally for treatment for hypertension, female?
- Costa Rica ranks 2nd and Kazakhstan ranks 3rd of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.